Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × Emtricitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 19 Vincristine 16 Cyclophosphamide 12 Zidovudine 11 Bleomycin 11 Etoposide 10 Rituximab 6 Interferon alpha-2 6 Cytarabine 6 Prednisone 5 Polymerase Chain Reaction 5 Liposomes 5 Dexamethasone 5 Biopsy 5 sargramostim 4 Specimen Handling 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Filgrastim 4 tecogalan 3 Paclitaxel 3 Nivolumab 3 Carmustine 3 interferon alfa-n1 2 fludarabine phosphate 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡